Welcome to the very preliminary website of the ‘Targeted Anti-Cancer Therapies’ (TACT) research project.

TACT is an European Training Network (ETN) funded by the European Commission under the ‘Horizon 2020 research and innovation programme’ and the ‘Marie Skłodowska-Curie actions’ (project N° 859458) that aims at developing the next generations of treatments against cancer.

ETNs bring together academic and industrial institutions within a consortium, in order to work on a central theme of research. By recruiting and hosting PhD students, insitutions from the consortium will equip them with transferable, future career-enhancing skills to create the next generation of experts in Europe.

The TACT ETN results from the collaboration between six universities and three companies located in five different European countries – see below and here. With a 3.1 M€ funding, TACT ambitions to train 11 PhD students in the development of state-of-the-art targeted anti-cancer therapeutics via carefully designed research projects and participation to several network-wide meetings, offering a comprehensive training in various scientific and non-scientific areas.

We are now recruiting 11 PhD students – check our research projects to find out more!

Beneficiary organisations forming the TACT consortium